Pathogenesis of allergic airway inflammation

Devendra K. Agrawal, Zhifei Shao

Research output: Contribution to journalReview article

93 Citations (Scopus)

Abstract

Advances have been made in defining the mechanisms for the control of allergic airway inflammation in response to inhaled antigens. Several genes, including ADAM33, DPP10, PHF11, GPRA, TIM-1, PDE4D, OPN3, and ORMDL3, have been implicated in the pathogenesis and susceptibility to atopy and asthma. Growing evidence associates asthma with a systemic propensity for allergic T-helper type 2 cytokines. Disordered coagulation and fibrinolysis also exacerbate asthma symptoms. Balance among functionally distinct dendritic cell subsets contributes to the outcome of T-cell-mediated immunity. Allergen-specific T-regulatory cells play a pivotal role in the development of tolerance to allergens and immune suppression. The major emphasis on immunotherapy for asthma during the past decade has been to direct the immune response to a type 1 response, or immune tolerance. In this review, we discuss the current information on the pathogenesis of allergic airway inflammation and potential immunotherapy, which could be beneficial in the treatment of airway inflammation, allergy, and asthma.

Original languageEnglish
Pages (from-to)39-48
Number of pages10
JournalCurrent Allergy and Asthma Reports
Volume10
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Asthma
Inflammation
Immunotherapy
Allergens
Immune Tolerance
Airway Management
Fibrinolysis
Regulatory T-Lymphocytes
Cellular Immunity
Dendritic Cells
Hypersensitivity
Cytokines
T-Lymphocytes
Antigens
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Pathogenesis of allergic airway inflammation. / Agrawal, Devendra K.; Shao, Zhifei.

In: Current Allergy and Asthma Reports, Vol. 10, No. 1, 01.2010, p. 39-48.

Research output: Contribution to journalReview article

@article{bb02b1eb7b004533b4fb36458d7a3dde,
title = "Pathogenesis of allergic airway inflammation",
abstract = "Advances have been made in defining the mechanisms for the control of allergic airway inflammation in response to inhaled antigens. Several genes, including ADAM33, DPP10, PHF11, GPRA, TIM-1, PDE4D, OPN3, and ORMDL3, have been implicated in the pathogenesis and susceptibility to atopy and asthma. Growing evidence associates asthma with a systemic propensity for allergic T-helper type 2 cytokines. Disordered coagulation and fibrinolysis also exacerbate asthma symptoms. Balance among functionally distinct dendritic cell subsets contributes to the outcome of T-cell-mediated immunity. Allergen-specific T-regulatory cells play a pivotal role in the development of tolerance to allergens and immune suppression. The major emphasis on immunotherapy for asthma during the past decade has been to direct the immune response to a type 1 response, or immune tolerance. In this review, we discuss the current information on the pathogenesis of allergic airway inflammation and potential immunotherapy, which could be beneficial in the treatment of airway inflammation, allergy, and asthma.",
author = "Agrawal, {Devendra K.} and Zhifei Shao",
year = "2010",
month = "1",
doi = "10.1007/s11882-009-0081-7",
language = "English",
volume = "10",
pages = "39--48",
journal = "Current Allergy and Asthma Reports",
issn = "1529-7322",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Pathogenesis of allergic airway inflammation

AU - Agrawal, Devendra K.

AU - Shao, Zhifei

PY - 2010/1

Y1 - 2010/1

N2 - Advances have been made in defining the mechanisms for the control of allergic airway inflammation in response to inhaled antigens. Several genes, including ADAM33, DPP10, PHF11, GPRA, TIM-1, PDE4D, OPN3, and ORMDL3, have been implicated in the pathogenesis and susceptibility to atopy and asthma. Growing evidence associates asthma with a systemic propensity for allergic T-helper type 2 cytokines. Disordered coagulation and fibrinolysis also exacerbate asthma symptoms. Balance among functionally distinct dendritic cell subsets contributes to the outcome of T-cell-mediated immunity. Allergen-specific T-regulatory cells play a pivotal role in the development of tolerance to allergens and immune suppression. The major emphasis on immunotherapy for asthma during the past decade has been to direct the immune response to a type 1 response, or immune tolerance. In this review, we discuss the current information on the pathogenesis of allergic airway inflammation and potential immunotherapy, which could be beneficial in the treatment of airway inflammation, allergy, and asthma.

AB - Advances have been made in defining the mechanisms for the control of allergic airway inflammation in response to inhaled antigens. Several genes, including ADAM33, DPP10, PHF11, GPRA, TIM-1, PDE4D, OPN3, and ORMDL3, have been implicated in the pathogenesis and susceptibility to atopy and asthma. Growing evidence associates asthma with a systemic propensity for allergic T-helper type 2 cytokines. Disordered coagulation and fibrinolysis also exacerbate asthma symptoms. Balance among functionally distinct dendritic cell subsets contributes to the outcome of T-cell-mediated immunity. Allergen-specific T-regulatory cells play a pivotal role in the development of tolerance to allergens and immune suppression. The major emphasis on immunotherapy for asthma during the past decade has been to direct the immune response to a type 1 response, or immune tolerance. In this review, we discuss the current information on the pathogenesis of allergic airway inflammation and potential immunotherapy, which could be beneficial in the treatment of airway inflammation, allergy, and asthma.

UR - http://www.scopus.com/inward/record.url?scp=76649112727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76649112727&partnerID=8YFLogxK

U2 - 10.1007/s11882-009-0081-7

DO - 10.1007/s11882-009-0081-7

M3 - Review article

VL - 10

SP - 39

EP - 48

JO - Current Allergy and Asthma Reports

JF - Current Allergy and Asthma Reports

SN - 1529-7322

IS - 1

ER -